Cabaletta Bio Receives FDA Fast Track Designation for CABA-201 Drug to Target Autoimmune Diseases
Cabaletta Bio received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug CABA-201.
Verismo Therapeutics Activates its STAR-101 Clinical Trial to Evaluate Investigational Drug SynKIR-110
Penn spinout Verismo Therapeutics, which focuses on CAR T-cell therapy for solid tumors, has activated its STAR-101 Phase 1 clinical trial at Penn.
PCI’s Carter Caldwell Is Interviewed on Launching a Startup
PCI’s Carter Caldwell, program director for the Penn Medicine Co-Investment Program, discussed his entrepreneurial career and shared advice for others looking to start businesses.
Penn Today explains how and why Penn research powers so many FDA-approved treatments
From CAR-T therapy to the mRNA covid-19 vaccine, the list of Penn-linked FDA approvals has been growing with each passing year.
PCI Participates in Philly Tech Week and Hosts “The Future of Wearable Technology”
On May 9th, PCI and the Philadelphia Alliance for Capital and Technologies (PACT) co-hosted the event "The Future of Wearable Technology" at the Pennovation Center as part of Philly Tech Week 2023
Meet the 2023/2024 PCI Fellows Cohort
Eleven fellows were admitted to the 2023/2024 cohort out of a large application pool.
Penn Medicine Magazine Showcases Penn’s Drug Research and Development and Commercial Partnerships
The Spring 2023 issue of Penn Medicine Magazine describes how Penn has become a hub for drug research and development and created the infrastructure in both supporting clinical research and forging co
President’s Innovation Prize to Sonura, a Group of Penn Engineering Undergraduates and Penn I-Corps Graduates Who Are Developing a Beanie to Promote Cognitive Development of Newborns in the NICU
Penn President Liz Magill awarded the 2023 President’s Innovation Prize toGabriella Daltoso, Sophie Ishiwari, Gabriela Cano, Caroline Amanda Magro, and Tifara Eliana Boyce for their project, Sonura.
Canberra IP and VL Navigator work together to improve the process of finding University available technologies on Inteum Technology Publisher
Canberra IP will now link to Visible Legacy (VL) Navigator to Search, Navigate, and Connect with context to facilitate and speed up communication with a university licensing office and inventors.
Philadelphia Business Journal Features Liz Magill and her Innovation Goals
In an interview about her long-term vision for the university with the Philadelphia Business Journal, Penn President Liz Magill mentions Penn’s breakthroughs in cell and gene therapy.